Načítá se...
Plakophilin-2 induced EGFR phosphorylation: a focus on the intracellular activators of EGFR
The oncogenic role of EGFR in many tumors has attracted a great deal of attention in the recent years and initiated the development of several potent EGFR inhibitors, which are used clinically for cancer treatment. However, the current therapeutic inhibition of EGFR signaling is limited to monoclona...
Uloženo v:
| Vydáno v: | Receptors Clin Investig |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4435607/ https://ncbi.nlm.nih.gov/pubmed/25995992 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14800/rci.485 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|